These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6283345)

  • 21. Adipose tissue lipoprotein lipase activity in type III hyperlipoproteinemia.
    Goldberg AP; Applebaum-Bowden DM; Hazzard WR
    Metabolism; 1979 Nov; 28(11):1122-6. PubMed ID: 226832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia.
    Langer T; Strober W; Levy RI
    J Clin Invest; 1972 Jun; 51(6):1528-36. PubMed ID: 4336943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electron microscopic structure of serum lipoproteins from patients with fish eye disease.
    Forte TM; Carlson LA
    Arteriosclerosis; 1984; 4(2):130-7. PubMed ID: 6704050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin.
    East CA; Grundy SM; Bilheimer DW
    Metabolism; 1986 Feb; 35(2):97-8. PubMed ID: 3633017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal low density lipoprotein metabolism in apolipoprotein E deficiency.
    Gabelli C; Gregg RE; Zech LA; Manzato E; Brewer HB
    J Lipid Res; 1986 Mar; 27(3):326-33. PubMed ID: 3734629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia.
    Falko JM; Schonfeld G; Witztum JL; Kolar J; Weidman SW
    Metabolism; 1979 Nov; 28(11):1171-7. PubMed ID: 226834
    [No Abstract]   [Full Text] [Related]  

  • 27. [Decreased concentration of low density lipoproteins (LDL) in malignant forms of monoclonal gammopathy].
    Fine JM; Fine A; Burstein M
    Rev Fr Transfus Immunohematol; 1982 Jun; 25(3):273-7. PubMed ID: 6810439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of correlation between the maximum low-density lipoprotein (LDL) receptor activity of blood lymphocytes and plasma LDL concentration in normal men.
    Cortese C; Turner PR; Marenah CB; Sule U; Price S; Miller NE; Lewis B
    Clin Sci (Lond); 1983 Jul; 65(1):95-8. PubMed ID: 6303675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease.
    Krauss RM
    Am Heart J; 1987 Feb; 113(2 Pt 2):578-82. PubMed ID: 3544774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of cholesterol synthesis by plasma lipoproteins from patients with abetalipoproteinemia.
    Alam NA; Illingworth DR; Sundberg EE; Alam SS
    Atherosclerosis; 1983 Dec; 49(3):295-305. PubMed ID: 6318779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic heterogeneity in very low-density lipoproteins.
    Shepherd J; Packard CJ
    Am Heart J; 1987 Feb; 113(2 Pt 2):503-8. PubMed ID: 3812208
    [No Abstract]   [Full Text] [Related]  

  • 32. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.
    Utermann G; Jaeschke M; Menzel J
    FEBS Lett; 1975 Aug; 56(2):352-5. PubMed ID: 169165
    [No Abstract]   [Full Text] [Related]  

  • 33. Unmasking of type III hyperlipoproteinemia by hypothyroidism: a dramatic illustration of altered lipoprotein metabolism in a postpartum woman.
    Retnakaran R; Connelly PW; Goguen J
    Endocr Pract; 2005; 11(6):394-8. PubMed ID: 16638727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.
    Morse JH; Witte LD; Goodman DS
    J Exp Med; 1977 Dec; 146(6):1791-803. PubMed ID: 200701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical type III hyperlipoproteinemia in a patient with Ig A myelomatosis.
    Feussner G; von Hodenberg E; Ziegler R
    Klin Wochenschr; 1990 May; 68(10):526-32. PubMed ID: 2374370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate content of human VLDL, IDL, LDL, and HDL plasma apoproteins from fasting normal and hyperlipemic patients.
    Fontaine M; Malmendier CL
    Clin Chim Acta; 1975 Oct; 64(1):91-3. PubMed ID: 171103
    [No Abstract]   [Full Text] [Related]  

  • 37. Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patient.
    Havekes LM; Gevers Leuven JA; van Corven E; de Wit E; Emeis JJ
    Eur J Clin Invest; 1984 Feb; 14(1):7-11. PubMed ID: 6321197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saturable high affinity binding, uptake and degradation of rat plasma lipoproteins by isolated parenchymal and non-parenchymal cells from rat liver.
    Van Berkel TJ; Kruijt JK; Van Gent T; Van Tol A
    Biochim Biophys Acta; 1981 Jul; 665(1):22-33. PubMed ID: 6269640
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia.
    Blom DJ; Byrnes P; Jones S; Marais AD
    J Lipid Res; 2003 Jan; 44(1):212-7. PubMed ID: 12518040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type III hyperlipoproteinemia: a focus on lipoprotein receptor-apolipoprotein E2 interactions.
    Innerarity TL; Hui DY; Bersot TP; Mahley RW
    Adv Exp Med Biol; 1986; 201():273-88. PubMed ID: 3026150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.